Multifaceted role of chemokines in solid tumors: From biology to therapy
S Raza, S Rajak, A Tewari, P Gupta… - Seminars in cancer …, 2022 - Elsevier
Chemokines are small secretory chemotactic cytokines that control the directed migration of
immune cells. Chemokines are involved in both anti-and pro-tumorigenic immune …
immune cells. Chemokines are involved in both anti-and pro-tumorigenic immune …
Blinatumomab added to chemotherapy in infant lymphoblastic leukemia
IM van der Sluis, P de Lorenzo… - … England Journal of …, 2023 - Mass Medical Soc
Background KMT2A-rearranged acute lymphoblastic leukemia (ALL) in infants is an
aggressive disease with 3-year event-free survival below 40%. Most relapses occur during …
aggressive disease with 3-year event-free survival below 40%. Most relapses occur during …
[HTML][HTML] A narrative review of central nervous system involvement in acute leukemias
D Deak, N Gorcea-Andronic, V Sas… - Annals of …, 2021 - ncbi.nlm.nih.gov
Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …
year more successful therapies are implemented. However, in a subset of cases the overall …
[HTML][HTML] Regulation and functions of α6-integrin (CD49f) in Cancer biology
R Khademi, H Malekzadeh, S Bahrami, N Saki… - Cancers, 2023 - mdpi.com
Simple Summary Integrins play key roles in mediating cell adhesion and delivering chemical
and mechanical signals to the interior of the cell. Consequently, they actively control cellular …
and mechanical signals to the interior of the cell. Consequently, they actively control cellular …
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
X Zhang, J Yang, J Li, W Li, D Song, X Lu, F Wu… - Cancer Immunology …, 2022 - Springer
CD19-targeted chimeric antigen receptor (CAR) T cell therapy has demonstrated striking
responses among B cell acute lymphoblastic leukemia (B-ALL), but analyses of potential …
responses among B cell acute lymphoblastic leukemia (B-ALL), but analyses of potential …
How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia
NE Kopmar, RD Cassaday - Blood, 2023 - ashpublications.org
The central nervous system (CNS) is the most important site of extramedullary disease in
adults with acute lymphoblastic leukemia (ALL). Although CNS disease is identified only in a …
adults with acute lymphoblastic leukemia (ALL). Although CNS disease is identified only in a …
[HTML][HTML] Immunotherapy approaches for hematological cancers
OL Lanier, E Pérez-Herrero, A PD'Andrea, K Bahrami… - Iscience, 2022 - cell.com
Hematological cancers such as leukemia, lymphoma, and multiple myeloma have
traditionally been treated with chemo and radiotherapy approaches. Introduction of …
traditionally been treated with chemo and radiotherapy approaches. Introduction of …
[HTML][HTML] Central nervous system prophylaxis and treatment in acute leukemias
Opinion statement Improvements in systemic therapy in the treatment of acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and …
leukemia (ALL) and acute myeloid leukemia (AML) have improved patient outcomes and …
[HTML][HTML] CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia
L Lenk, M Carlet, F Vogiatzi, L Spory… - Communications …, 2021 - nature.com
Central nervous system (CNS) involvement remains a challenge in the diagnosis and
treatment of acute lymphoblastic leukemia (ALL). In this study, we identify CD79a (also …
treatment of acute lymphoblastic leukemia (ALL). In this study, we identify CD79a (also …
[HTML][HTML] Linear and circular long non-coding RNAs in acute lymphoblastic leukemia: from pathogenesis to classification and treatment
Y Maimaitiyiming, L Ye, T Yang, W Yu… - International Journal of …, 2022 - mdpi.com
The coding regions account for only a small part of the human genome, and the remaining
vast majority of the regions generate large amounts of non-coding RNAs. Although non …
vast majority of the regions generate large amounts of non-coding RNAs. Although non …